38 results on '"Geisbert, Thomas W."'
Search Results
2. Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins
3. Combination therapy protects macaques against advanced Marburg virus disease
4. A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus
5. Antibodies periodically wax and wane in survivors of Ebola
6. Establishment of an African green monkey model for COVID-19 and protection against re-infection
7. Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages
8. Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase
9. Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatment
10. Immune correlates of postexposure vaccine protection against Marburg virus
11. Rational design of universal immunotherapy for TfR1-tropic arenaviruses
12. Antagonism of STAT1 by Nipah virus P gene products modulates disease course but not lethal outcome in the ferret model
13. An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections
14. Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever
15. Author Correction: Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants
16. Erratum: Post-exposure treatments for Ebola and Marburg virus infections
17. Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever
18. Post-exposure treatments for Ebola and Marburg virus infections
19. Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever
20. Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants
21. Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA
22. Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy
23. Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits
24. The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset
25. The immunomodulating V and W proteins of Nipah virus determine disease course
26. Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates
27. Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus
28. 重症エボラウイルス感染症のサルを回復させた治療薬
29. Ebola therapy protects severely ill monkeys
30. Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease
31. CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates
32. Pathogenesis of lassa fever in cynomolgus macaques
33. Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations
34. The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever
35. Analysis of the expressed heavy chain variable-region genes of Macaca fascicularis and isolation of monoclonal antibodies specific for the Ebola virus' soluble glycoprotein
36. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses
37. Exotic emerging viral diseases: progress and challenges
38. Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.